Uncategorized Guest User 8/2/13 Uncategorized Guest User 8/2/13 Congress Leaves ... With No Clear Pathway Ahead Read More Uncategorized Guest User 8/2/13 Uncategorized Guest User 8/2/13 Sequestration as Government Malpractice: Op Ed and more Read More Uncategorized Guest User 7/26/13 Uncategorized Guest User 7/26/13 The GIGO Effect, FDA's Budget, and FDA Spending Read More Advocacy at a Glance Guest User 7/26/13 Advocacy at a Glance Guest User 7/26/13 FDA-Regulated Industries are a Backbone of the U.S. Economy and more Read More Uncategorized Guest User 7/19/13 Uncategorized Guest User 7/19/13 FY 14, Sequestration, and the Eshoo Initiative Read More Advocacy at a Glance Guest User 7/19/13 Advocacy at a Glance Guest User 7/19/13 Representative Eshoo Introduces User Fee Sequester Legislation Read More Uncategorized Guest User 7/12/13 Uncategorized Guest User 7/12/13 Time for a Review of the FY 14 Budget Status Read More Uncategorized Guest User 7/12/13 Uncategorized Guest User 7/12/13 Stripped-down Farm Bill Passes House and more Read More Advocacy at a Glance Guest User 6/28/13 Advocacy at a Glance Guest User 6/28/13 Why the Farm Bill May Impact the FDA Budget Read More Advocacy at a Glance Guest User 6/28/13 Advocacy at a Glance Guest User 6/28/13 Next Step in Agriculture/FDA Spending Bill: Floor Time and more Read More Uncategorized Guest User 6/21/13 Uncategorized Guest User 6/21/13 Approved Budget Marks: Early, Up, but Still to Be Resolved Read More Advocacy at a Glance Guest User 6/21/13 Advocacy at a Glance Guest User 6/21/13 Sequestered User-Fee Funds and more Read More Uncategorized Guest User 6/14/13 Uncategorized Guest User 6/14/13 Just a Few More Things for FDA to Focus on Read More Advocacy at a Glance Guest User 6/14/13 Advocacy at a Glance Guest User 6/14/13 Animal Drug and Animal Generic Drug User Fee Reauthorization Act Signed into Law and more Read More Uncategorized Guest User 6/9/13 Uncategorized Guest User 6/9/13 Full Committee Mark-up of House Appropriations Bill This Thursday Read More Uncategorized Guest User 6/7/13 Uncategorized Guest User 6/7/13 House Exceptionalizes FDA for FY 14 ... But More Needed Read More Advocacy at a Glance Guest User 6/7/13 Advocacy at a Glance Guest User 6/7/13 Congressional Efforts Continue on User Fees and Sequester and more Read More Uncategorized Guest User 6/4/13 Uncategorized Guest User 6/4/13 Alliance Praises Prioritization of FDA in FY 14 Appropriations Process Read More Uncategorized Guest User 5/31/13 Uncategorized Guest User 5/31/13 What Authorizers and Appropriators Are Doing -- The Disconnect Read More Advocacy at a Glance Guest User 5/31/13 Advocacy at a Glance Guest User 5/31/13 Alliance’s New FDA Budget Primer Attached and more Read More Newer Posts Older Posts
Uncategorized Guest User 8/2/13 Uncategorized Guest User 8/2/13 Congress Leaves ... With No Clear Pathway Ahead Read More
Uncategorized Guest User 8/2/13 Uncategorized Guest User 8/2/13 Sequestration as Government Malpractice: Op Ed and more Read More
Uncategorized Guest User 7/26/13 Uncategorized Guest User 7/26/13 The GIGO Effect, FDA's Budget, and FDA Spending Read More
Advocacy at a Glance Guest User 7/26/13 Advocacy at a Glance Guest User 7/26/13 FDA-Regulated Industries are a Backbone of the U.S. Economy and more Read More
Uncategorized Guest User 7/19/13 Uncategorized Guest User 7/19/13 FY 14, Sequestration, and the Eshoo Initiative Read More
Advocacy at a Glance Guest User 7/19/13 Advocacy at a Glance Guest User 7/19/13 Representative Eshoo Introduces User Fee Sequester Legislation Read More
Uncategorized Guest User 7/12/13 Uncategorized Guest User 7/12/13 Time for a Review of the FY 14 Budget Status Read More
Uncategorized Guest User 7/12/13 Uncategorized Guest User 7/12/13 Stripped-down Farm Bill Passes House and more Read More
Advocacy at a Glance Guest User 6/28/13 Advocacy at a Glance Guest User 6/28/13 Why the Farm Bill May Impact the FDA Budget Read More
Advocacy at a Glance Guest User 6/28/13 Advocacy at a Glance Guest User 6/28/13 Next Step in Agriculture/FDA Spending Bill: Floor Time and more Read More
Uncategorized Guest User 6/21/13 Uncategorized Guest User 6/21/13 Approved Budget Marks: Early, Up, but Still to Be Resolved Read More
Advocacy at a Glance Guest User 6/21/13 Advocacy at a Glance Guest User 6/21/13 Sequestered User-Fee Funds and more Read More
Uncategorized Guest User 6/14/13 Uncategorized Guest User 6/14/13 Just a Few More Things for FDA to Focus on Read More
Advocacy at a Glance Guest User 6/14/13 Advocacy at a Glance Guest User 6/14/13 Animal Drug and Animal Generic Drug User Fee Reauthorization Act Signed into Law and more Read More
Uncategorized Guest User 6/9/13 Uncategorized Guest User 6/9/13 Full Committee Mark-up of House Appropriations Bill This Thursday Read More
Uncategorized Guest User 6/7/13 Uncategorized Guest User 6/7/13 House Exceptionalizes FDA for FY 14 ... But More Needed Read More
Advocacy at a Glance Guest User 6/7/13 Advocacy at a Glance Guest User 6/7/13 Congressional Efforts Continue on User Fees and Sequester and more Read More
Uncategorized Guest User 6/4/13 Uncategorized Guest User 6/4/13 Alliance Praises Prioritization of FDA in FY 14 Appropriations Process Read More
Uncategorized Guest User 5/31/13 Uncategorized Guest User 5/31/13 What Authorizers and Appropriators Are Doing -- The Disconnect Read More
Advocacy at a Glance Guest User 5/31/13 Advocacy at a Glance Guest User 5/31/13 Alliance’s New FDA Budget Primer Attached and more Read More